Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Dumbeldorfwhiteon Sep 15, 2024 3:40am
143 Views
Post# 36224228

RE:More Than $7 With Combined Indications

RE:More Than $7 With Combined IndicationsCan almost guarantee There ain't a single company out there that's going to give you 300m to a company that is so strapped for cash and in such a weak negotiating position.

as far as the FDA goes your post is laughable. So who was responsible for:

The first 12 being underdosed, and why did it take them so long to realize it. I mean that's a year and a half at their enrollment pace lmao

The slow slow slow enrollment. Remember their goal was to have everyone finished and treated by year end and was supposed to be 100 patients, now all the sudden there is talks of less, gee wonder why?

The slow slow slow onboarding of new clinical sites, again reflects that they likely cant due to cash issues. 

Not being aware that data should be tracked for 450 days.  I mean I tried to tell everyone how hard it would be to track people down after they leave a study.

the excuses you guys come up with give me the greatest pleasure kee em coming!
<< Previous
Bullboard Posts
Next >>